Breckenridge Pharmaceuticals, Metabolite Labs, and Pamlab Sue Macoven Pharmaceuticals
December 14, 2011
Breckenridge Pharmaceuticals, Metabolite Labs, and Pamlab filed suit against Macoven Pharmaceuticals over a patent related to compositions for preventing or reducing elevated metabolic levels. 12/9, Southern District of New York, 1:2011cv09022.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.